Motif Bio raises £2.7 million via share placing
Motif Bio has announced that it has raised £2.7 million from a share placing, to provide additional working capital.
Read More
Tag: shares
Pfizer buys stake in French gene therapy company Vivet
Pfizer has announced a collaboration with Vivet on the development of a potential breakthrough therapy for Wilson disease.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
